A new study has looked into how effective COVAX has been in its central aim: reducing the disparity between rich and poor when it comes to access to COVID-19 vaccines.
Thank you for visiting our website. Your input and time is valuable in helping us improve your experience. Please take less than a minute to provide feedback on your visit.